Skip to main content

Specialties
Resources for Physicians
Resources for Your Patients

Search Videos and More

search

Channel Categories

Cancer (121)
Cardiology, Heart & Vascular Surgery (4)
Diabetes & Endocrinology (2)
Gastroenterology (8)
Geriatric Medicine (2)
Neurology (3)
Neurosurgery (2)
Obstetrics & Gynecology (7)
Ophthalmology (3)
Orthopaedics (3)
Other Programs (1)
Otolaryngology (2)
Physical Medicine and Rehabilitation (2)
Psychiatry (2)
Pulmonology (3)
Rheumatology (1)
Urology (2)

Types

News (107)
CME Course (2)
Video Asset (12)

Conditions

[A06.4] Amebic liver abscess (1)
[C01] Tongue Cancer (1)
[C14] Throat Cancer (1)
[C18.9] Colorectal Cancer (1)
[C22.0] Liver cell carcinoma (1)
[C22.3] Angiosarcoma of liver (1)
[C22.8] Liver Cancer (3)
[C25.3] Pancreatic Cancer (6)
[C34.90] Lung Cancer (2)
[C43.0] Malignant melanoma of lip (1)
[C43.1] Malignant melanoma of eyelid, including canthus (1)
[C44.90] Skin Cancer (3)
[C50.1] Malignant neoplasm of central portion of breast (1)
[C50.919] Triple-negative Breast Cancer (5)
[C50.91] Malignant neoplasm of breast of unspecified site, female (1)
[C50.9] Malignant neoplasm of breast of unspecified site (1)
[C50] Breast Cancer (7)
[C53.0] Malignant neoplasm of endocervix (1)
[C53.1] Malignant neoplasm of exocervix (1)
[C53.8] Malignant neoplasm of overlapping sites of cervix uteri (1)
[C53.9] Malignant neoplasm of cervix uteri, unspecified (1)
[C53] Malignant neoplasm of cervix uteri (1)
[C61] Prostate Cancer (1)
[C64] Kidney Cancer (1)
[C71.9] Glioblastoma (2)
[C76.0] Head and Neck Cancer (2)
[C78.6] Secondary malignant neoplasm of retroperitoneum and peritoneum (1)
[C79.89] Secondary malignant neoplasm of other specified sites (1)
[C80.0] Disseminated malignant neoplasm, unspecified (1)
[C80.1] Malignant (primary) neoplasm, unspecified (2)
[C80] Malignant neoplasm without specification of site (1)
[D72.0] Genetic anomalies of leukocytes (1)
[G62.82] Radiation-induced polyneuropathy (1)
[H05.32] Deformity of orbit due to bone disease (1)
[I42.7] Cardiomyopathy due to drug and external agent (1)
[I42] Cardiomyopathy (1)
[K86.9] Disease of pancreas, unspecified (1)
[M89.9] Metabollic Bone Disease (1)
[N39.0] Urinary Tract Infection (1)
[Z15.01] BRCA1 and BRCA2 Mutations (1)
[Z68.5] Body mass index (BMI) pediatric (1)

Procedures

[0003U] Measurement of proteins associated with ovarian cancer in serum (3)
[0005U] Test for detecting genes associated with prostate cancer in urine (3)
[0014U] DNA test for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow (1)
[0022U] DNA and RNA gene analysis for non-small cell lung cancer (1)
[0030U] Gene analysis of targeted sequences for warfarin drug response (1)
[0036U] Exome gene analysis for somatic mutation in tumor tissue (1)
[0067U] Protein expression profiling of 4 biomarkers of breast cancer in precancerous breast tissue (1)
[00702] Anesthesia for liver biopsy (accessed through the skin) (1)
[00732] Anesthesia for diagnostic examination of gallbladder and pancreatic, liver, and bile ducts using an endoscope (2)
[0102U] Gene sequence analysis panel of 17 genes associated with hereditary breast cancer and related disorders (1)
[0131U] Targeted mRNA sequence analysis of 13 genes associated with hereditary breast cancer and related disorders (1)
[0166U] Liver disease test panel in serum specimen (1)
[0172U] DNA gene analysis (BRCA1, DNA repair associated and BRCA2, DNA repair associated) for detection of mutations associated with breast cancer (1)
[01922] Anesthesia for X-ray or radiation therapy (1)
[19294] Preparation of tumor cavity and placement of radiation therapy applicator into breast for radiation therapy concurrent with partial breast removal (2)
[19303] Mastectomy (1)
[28540] Closed treatment of ankle joint bone dislocation (1)
[28545] Closed treatment of ankle joint bone dislocation under anesthesia (1)
[48150] Whipple Procedure (2)
[49327] Examination of abdomen with insertion of devices for radiation therapy using endoscope (1)
[58210] Abdominal removal of uterus, cervix, and lymph nodes on both sides of pelvis and aortic lymph node biopsy (1)
[77261] Management of radiation therapy, simple (12)
[77262] Management of radiation therapy, intermediate (2)
[77263] Management of radiation therapy, complex (1)
[77427] Radiation Therapy (1)
[77799] Administration of radiation therapy (10)
[78815] Nuclear medicine study with CT imaging skull base to mid-thigh (1)
[81479] Molecular pathology procedure (1)
[87086] Bacterial colony count, urine (1)
[87088] Bacterial urine culture (1)
[87184] Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) (1)
[87186] Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (1)
[96366] Infusion into a vein for therapy, prevention, or diagnosis (1)
[96377] Application of on-body injector for injection under skin (1)
[96401] Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle (3)
[96402] Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle (1)
[96405] Chemotherapy into a lesion, up to and including 7 lesions (2)
[96406] Chemotherapy into a lesion, more than 7 lesions (1)
[96409] Infusion of chemotherapy into a vein using push technique (2)
[99202] New patient outpatient visit, total time 15-29 minutes (1)
[99203] New patient outpatient visit, total time 30-44 minutes (1)
[99204] New patient outpatient visit, total time 45-59 minutes (1)
[99205] New patient outpatient visit, total time 60-74 minutes (1)
[99212] Established patient outpatient visit, total time 10-19 minutes (1)
[99213] Established patient outpatient visit, total time 20-29 minutes (1)
[99214] Established patient outpatient visit, total time 30-39 minutes (1)
[99215] Established patient outpatient visit, total time 40-54 minutes (1)

Showing 13 - 24 of 121 results

Previous| 1 | 2 | 3 ...11 |Next

Time in a bottle: How UTSW paved the way for a breakthrough brain cancer drug

Time in a bottle: How UTSW paved the way for a breakthrough brain cancer drug

Nearly two decades of innovative research and clinical trials culminated in the FDA approval of a pill that gives fresh hope to low-grade glioma patients

Gene-editing system targets multiple organs simultaneously

Gene-editing system targets multiple organs simultaneously

Tool developed at UT Southwestern corrects mutation that affects the liver and lungs in model of rare genetic disease

Protein pivotal for B-cell cancers gets a closer look

Protein pivotal for B-cell cancers gets a closer look

Structural insights from cryo-electron microscopy could lead to drugs that target midnolin in leukemias, lymphomas, and multiple myelomas

Study uncovers how biomolecular condensates cause some kidney cancers

Study uncovers how biomolecular condensates cause some kidney cancers

Mechanism discovered by UTSW researchers could offer targets for novel cancer therapies

Tongue squamous cell carcinoma

Tongue squamous cell carcinoma

Tongue squamous cell carcinoma resected with the Intuitive DaVinci® SP Robotic System shows fluorescence from IV-injected Pegsitacianine, a pH-sensitive nanoparticle that selectively labels cancer. The built-in Firefly near-infrared imaging confirms compatibility with the robotic system and enables clear tumor visualization.

CPRIT Awards: Dr. Asal Rahimi & Dr. Raquibul Hannan

CPRIT Awards: Dr. Asal Rahimi & Dr. Raquibul Hannan

UT Southwestern’s Department of Radiation Oncology has recently won two Cancer Prevention and Research Institute of Texas (CPRIT) awards. The recipients are Raquibul Hannan, M.D., Ph.D., Professor of Radiation Oncology and Chief of Genitourinary Radiation Oncology Service, and Asal Rahimi, M.D., M.S., Professor of Radiation Oncology, Associate Vice Chair for Program Development, Medical Director of the SCCC Clinical Research Office, and Chief of Breast Radiation Oncology Service.

Enhancing Breast Patients’ Experience Through Adaptive IMRT Study

Enhancing Breast Patients’ Experience Through Adaptive IMRT Study

Standard whole-breast radiation treatment in the U.S. ranges between a conventional five-to six-week course of 60 Gray in 30 fractions or a three- to four-week hypofractionated course of 40 Gray in 15 fractions.

Applying Lessons Learned from Cancer to Treat Autoimmune Diseases

Applying Lessons Learned from Cancer to Treat Autoimmune Diseases

Through cancer immunotherapy research efforts, Andrew Wang, M.D., FAIMBE, FAAAS, Professor of Radiation Oncology and Vice Chair, Translational Research & Commercialization, and his research team are finding novel ways to treat previously incurable autoimmune diseases.

UT Southwestern scientists develop ‘self-driving’ microscope

UT Southwestern scientists develop ‘self-driving’ microscope

Novel microscope and software allow imaging at different scales, tracking biological processes over long time periods

Preoperative immunotherapy could enhance breast cancer cure rates

Preoperative immunotherapy could enhance breast cancer cure rates

Clinical trial shows new therapy holds promise for patients with subtype carrying high risk for metastasis

Diagnosis Of Rare Cancer Led To Lifesaving Surgery and Access to Clinical Trial Treatment at UT Southwestern

Diagnosis Of Rare Cancer Led To Lifesaving Surgery and Access to Clinical Trial Treatment at UT Southwestern

With the expertise of Jayanthi Lea, M.D., a patient with low-grade serous ovarian carcinoma is now in remission.

Shorter, safer protocol effectively treats triple-negative breast cancer

Shorter, safer protocol effectively treats triple-negative breast cancer

Adding radiation at start of treatment regimen produced results similar to current standard of care with fewer toxic side effects

Showing 13 - 24 of 121 results

Previous| 1 | 2 | 3 ...11 |Next

Powered by BROADCASTMED

About UT Southwestern Medical Center

UT Southwestern, one of the nation’s premier academic medical centers, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty members have received six Nobel Prizes and include 25 members of the National Academy of Sciences, 24 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 3,200 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in more than 80 specialties to more than 120,000 hospitalized patients, more than 360,000 emergency room cases, and oversee nearly 5 million outpatient visits a year.